Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Relief Therapeutics Holdings
Geneva, Geneva, Switzerland
- Ownership
- Private
- Employees
- ~49
- Development stage
- Other
01
Overview
Relief Therapeutics has achieved regulatory progress with RLF-TD011 in epidermolysis bullosa (Orphan Drug designation, active pre-IND process), positive results with RLF-OD032 for PKU in liquid sapropterin formulation, and commercialized multiple niche rare disease products via partners. RLF-100 (aviptadil) completed Phase II ARDS trials; products like PKU GOLIKE and diclofenac formulations are marketed in EU/US[4][5][6][13][14].
- Therapeutic areas
- RheumatologyPulmonologyMetabolic DisordersDermatologyOncology
- Modalities
- Small moleculeBiologicProteinHypochlorous acid topical solutionSynthetic peptide (for RLF-100/aviptadil)Medical food (for PKU GOLIKE)
- Industry
- Biotech
02
Partnerships
Assertio Therapeutics (CAMBIA)Novartis (Voltfast)Ratiopharm (Diclo-ratiopharm)DLBEEN (Potafast)Fidia Farmaceutici (Voltadol)Acer Therapeutics (ACER-001/OLPRUVA)Eton Pharmaceuticals (PKU GOLIKE US rights)Nutrisens (PKU GOLIKE ex-US rights)Texas-based APR (PKU GOLIKE KRUNCH)SWK Holdings (Nexodyn AOS financing)
Beyond the preview
Go deeper on Relief Therapeutics Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Relief Therapeutics Holdings.